Introduction
Although genome-wide association studies (GWAS) have identified thousands of genetic variants that associated with different complex diseases, a wide gap exists between the estimates of heritability and the heritability that are explained by the genetic variants via GWAS (Vineis 2010 [1] ). The potential reasons for the missing heritability include myriads of common variants with small effects yet to be found, rare variants and structure variants (insertions, deletions, duplications, inversions, translocations, and copy-number variants) that are poorly detected by available genotyping arrays, and insufficient capability to detect epistasis effects, parental age effects, epigenetic effects, and gene-environment (G×E) interactions (Goriely 2010 [2] ) (Eichler 2010 [3] ) (Clarke 2010 [4] ) (Manolio 2009 [5] ) (Marian 2012 [6] ) (Quigley 2012 [7] ) (Zaitlen 2012 [8] ) (Gibson 2010 [9] ) (Zuk 2012 [10] ). Yang et al. reported a joint estimate of all SNPs, and found that their method (GCTA) can explain a large proportion of the heritability for human height (Yang 2010 [11] ). Park et al. re-examined existing GWAS to estimate the number of susceptible loci and the distribution of their effect sizes. They used such estimates to ascertain power and sample-size requirements for future new GWAS or meta-analyses (Park 2010 [12] ). Heritability on the liability scale estimated by GCTA ranged from 0.05 to 0.38 across 13 cancer types (Sampson 2015 [13] ). These studies argued that a large proportion of the missing heritability can be explained by common variants. Previous study have demonstrated that 1000 Genomes-based imputation could identify both novel and refined association loci due to the increased density of marks (Huang 2012 [14] ) (Herold 2016 [15] ). We hypothesize that the increased density of GWAS marks will also facilitate the investigation of missing heritability without the need for additional genotyping or sequencing. We use IMPUTE2 (Howie 2009 [16] ) for genotype imputation and then apply GCTA (Yang 2011 [17] ) to the association results before and after imputation to estimate the heritability of each disease.
BD: bipolar disorder; CAD: coronary artery disease; CD: Crohn's disease; RA: rheumatoid arthritis; T1D: type 1 diabetes; T2D: type 2 diabetes; K: prevalence; VE: explained variance; SE: standard error. a: Genome-wide association analysis without imputation. b: Genome-wide association analysis with imputation using 1000 Genomes data as reference panel. 
Results & Discussion
After quality control, a total of 444,167 SNPs for 16,179 individuals were retained for the initial association analysis. These SNPs were used as the input genotype data for imputation. Approximately 2.7 million SNPs for each trait were used for association analysis after imputation. The estimation of the phenotypic variance explained by all SNPs with p-value less than 1 × 10-8 was performed using the restricted maximum likelihood (REML) analysis, which was implemented in GCTA (Yang 2011 [17] ). Figure 1 shows the number of SNPs and the estimate of phenotypic variance was explained by these SNPs for the six traits. The numbers of SNPs that passed the significant threshold increased more than ten times after imputation compared with the number before imputation. Before imputation, only several to 12.65 percent of the phenotypic variance was explained by the significant SNPs. After imputation, 25.52% to 56.28% of the phenotypic variance was explained by the significant SNPs. SNPs with p-value less than 1 × 10-8 after imputation can explain 33.91% to 40.40% of BD phenotypic variance when different prevalence was used. The proportion of phenotypic variance explained by genetic variants in T1D was almost tripled in the 1000 Genomes imputation-based association analysis than in the association analysis without imputation. The explained proportion of phenotypic variance were increased approximately 14 and 17 times in RA and CD, respectively. The proportion were increased even higher in CAD and T2D, about 62 and 95 times, respectively.
We then grouped SNPs with association p-value reached the genome-wide significant level (1 × 10-8) after imputation but were not in LD (r2 > 0.8) with any SNP with association p-value less than 1 × 10-5 before imputation as "novel" SNPs. The number of "novel" SNPs and the estimate of phenotypic variance explained by them for the six traits were listed in Figure 2 . The results suggested that the novel SNPs are the main reasons behind the increasing of heritability estimate. Since most variants have relatively small effect size, sample size of most studies were not big enough, and the limitation of current genotyping technology, more common variants with intermediate effect and rare variants may be with large effect are yet to be identified. These variants should be tractable through large meta-analysis and imputation-based association analysis. This is the first study that comprehensively examined the utility of 1000 Genomes-based imputation for finding missing heritability. The proportion of phenotypic variance that was explained by genetic variants increased when the contribution of these new variants was included. These findings support that a larger number of variants are yet to be found. These variants are potential sources of missing heritability.
Conclusions
The new additional identified trait-associated variants identified through 1000 genome based imputation can explain part of missing heritability.
Limitations
One potential problem is that the heritability estimates produced by GCTA is sensitive to the chosen sample and may be biased (Krishna Kumar_2015 [18] ). Although the 1000 Genomes-based imputation increased the proportion of phenotypic variance explained by genetic variants, a substantial proportion of heritability remains unexplained for these diseases. The next-generation sequencing data will accelerate the process of exploring missing heritability. With the rapid increase of the implementation of next-generation sequencing technology, large scale next-generation sequence data from well-phenotyped individuals will be available. It will be a great opportunity to unveil the missing heritability unexplained by common variants that were not covered by current genome-wide association studies. 
